Ask about our free Pilot2Partnership program
Learn more
How it works
Prove it on your protein first. Then scale.
1
Pilot
A free pilot lot made to agreed specs, with a full QC data package. You judge it in your own workflow.
2
Scale-up
We lock the process, align QC to your assays, and agree formulation and packaging.
3
Supply
Recurring lots sized to your forecast, with lot-specific CoAs.
Enzyme
Needed
No
Available
Commercially?
Yes
In- House
Expertise?
No
Quality & Cost
Acceptable?
Yes
No
Yes
Make
in-house
Outsource
Compare offerings from commercial suppliers
Spend weeks or months developing products
Trial and error to find reagent that works
Costs savings possible, but opportunity costs of resources committed to non-critical path development
Costs can be prohibitive, even for large companies
About TriAltus Bioscience
Taking the pain
out of outsourcing
At TriAltus, we understand the real-world challenges research teams face when it comes to sourcing high-quality recombinant proteins. Specialty enzymes are essential tools in drug discovery, diagnostics, and synthetic biology — but too often, their cost forces teams to bring production in-house, diverting time, talent, and equipment away from core scientific work.
We believe you shouldn’t have to choose between quality and affordability.
That’s why we built our enzyme platform around CLīM™, a proprietary purification technology that delivers ultra-pure, high-performance proteins in a single purification step. By dramatically lowering the cost of manufacturing, we’re able to pass meaningful savings on to you — making it easier than ever to source the reagents you need without sacrificing quality or scalability.
Whether you're advancing a CRISPR workflow, building a diagnostic assay, or scaling a bioproduction process, TriAltus gives you access to the performance you expect — at a price that lets your team stay focused on what matters most.
Purity, performance, price — you don’t have to compromise.
By the numbers
Average purity
higher avg titer
lower avg cost
Years of service
Customers
Technology
Powered by CLīM™
Dr. Jennifer Doudna was a co-inventor of CRISPR-Cas 9 gene editing technology, for which she earned the Nobel Prize in Chemistry in 2020. Since 2021, scientists in Doudna’s lab at UC Berkeley have produced more than 100 CRISPR enzymes using TriAltus’ CLīM™ purification system. The same purification technology trusted in CRISPR discovery is behind every TriAltus enzyme.
Recent citations:
Learn more -> about the study in Nature Biotechnology (2024)
Learn more -> about the study in Nucleic Acids Research (2025)
Dr. Jennifer Doudna in Berkeley, Calif., on Jan. 18, 2019.Anastasiia Sapon—The New York Times/Redux
Capabilities and Add on Services
TriAltus Capabilities
Solubility testing
Early solubility checks to ensure protein stability and usability.
FPLC purification
High-resolution purification for precise, reproducible results.
Standard QC quantitation
Reliable quality control with accurate protein quantification.
ISO13485-compliant manufacturing
Strict regulatory compliance for diagnostic-grade proteins.
Custom formulation and packaging
Tailored formulations and packaging designed for downstream applications.
Flexible scale from 10 mg to >100 g
Scalable production to match both research and commercial requirements.
Need research quantities today?
Off-the-shelf enzymes ship from stock, and every one is available in bulk.
Articles
Insights to keep you informed
Explore our expert insights, guides, and breaking news written to keep you informed & prepared
Tell us about your protein.
Qualifying projects get a free pilot lot through Pilot2Partnership™.